Registro:

Referencias:

• Castelli, M., Malagoli, M., Ipazzio Ruberto, A., Baggio, A., Casolari, C.H., Cermelli, C., Bossa, M.R., Roffia, S., In-vitro studies of two 5-nitroimidazole derivatives (1997) J Ant Chemoter, 40, pp. 19-25
• Cosar, C., Julou, L., Activité de l'(hydroxy-e-ethyl)-1-methyl-2-nitro-5-imidazole (8.823R.P) vis-à-vis des infections expérimentales à Trichomonas vaginalis (1959) Ann Inst Pasteur (Paris), 96, p. 238
• Burchard, G.D., Mirelman, D., Entamoeba hystolitica: Virulence potential and sensitivity to metronidazole and emetine of four isolates possessing non-pathogenic zymodemes (1988) Exp Parasitol, 66, pp. 231-242
• Baines, E.I., Metronidazole: Sixteen years of developments (1978), pp. 61-71. , Finegold S, editor. Metronidazole. Amsterdam: Excepta Medica; Ings, R.M.J., McFadzean, J.A., Ormerod, W.E., The mode of action of metronidazole in Trichomona vaginalis and other microorganisms (1974) Biochem Pharmacol, 23, pp. 1421-1429
• Ludlum, D.B., Colinas, R.J., Kirk, M.C., Mehta, J.R., Reaction of reduced Metronidazole with guanosine to form an unstable adduct (1988) Carcinogenesis, 9, pp. 593-596
• Mohindra, J.K., Rauth, A.M., Increased cell killing by metronidazole and nitrofurazone of hipoxic compared to aerobic mammalian cells (1976) Cancer Res, 36, pp. 930-936
• La Russo, N.F., Tomasz, M., Müller, M., Lipman, R., Interaction of metronidazole with nucleic acids "in vitro" (1977) Mol Pharmacol, 13, pp. 872-882
• Knight, R.C., Skolimowsky, I.M., Edwards, D.J., The interaction of reduced Metronidazole with DNA (1978) Biochem Pharmacol, 27, pp. 2089-2093
• Probst, G.S., McMahon, R.E., Hill, E.E., Thompson, C.Z., Epp, J.K., Neal, S.B., Chemically-induced unscheduled DNA synthesis in primary rat hepatocyte cultures: A comparison with bacterial mutagenicity using 218 compounds (1981) Environ Mutagen, 3, pp. 11-32
• Sina, J.F., Bean, C.L., Dysart, G.R., Taylor, V.I., Bradley, M.O., Evaluation of the alkaline elution rat hepatocyte assay as a predictor of carcinogenic/mutagenic potential (1983) Mutation Res, 113, pp. 357-391
• Mitelman, F., Hartley-Asp, B., Ursing, B., Chromosome aberrations and metronidazole (1976) Lancet, p. 802
• Hartley-Asp, B., Absence of chromosomal damage in the lymphocytes of patients treated with metronidazole for Trichomonas vaginalis (1979) Toxicol Lett, 4, pp. 15-19
• Dobías, L., Cerna, M., Rossner, P., Sram, R., Genotoxicity and carcinogenicity of metronidazole (1994) Mutation Res, 317, pp. 177-194
• Burtin, P., Taddio, A., Ariburnu, O., Einarson, T.R., Koren, G., Safety of metronidazole in pregnancy: A meta-analysis (1995) A. J Obstet Gynecol, 172, pp. 525-529
• Ivanov, I., The effect of "Trichomonacid" on pregnancy in experimental animals (1969) Akushervo Gynekologya, 8, pp. 241-244
• Chacko, M., Bhide, S.V., Carcinogenicity, perinatal carcinogenicity and teratogenicity of low dose metronidazole (MNZ) in Swiss mice (1986) J Cancer Res, 112, pp. 135-140
• Giknis, M.L.A., Damjanov, I., The transplacental effects of ethanol and metronidazole in Swiss Webster mice (1983) Toxicol Lett, 19, pp. 37-42
• Mudry, M., Carballo, M.A., Labal de Vinuesa, M., Larripa, I., Mutagenic bioassays of certain pharmacological drugs: III Metronidazole (MTZ) (1994) Mutation Res, 305, pp. 127-132
• Cox, B.D., Lyon, M.F., X-ray induced dominant lethal mutations in mature and immature oocytes of guinea pigs and golden hamsters (1975) Mutation Res, 28, pp. 421-436
• Zar, J., (1984) Biostatistical analysis, 201, pp. 292-298. , New York: Prentice-Hall, Inc
• Cosar, C., Ganter, P., Julou, L., Étude expérimentale du métronidazole, 8223 RP: Activités trichomonacide et amoebicide. Toxicité et propriétés pharmacologiques générales (1969) Presse Medicale, 69, pp. 1969-1972
• Jokipii, L., Jokipii, M.M., In vitro susceptibility of Giardia liamblia trophozoites to metronidazole and tinidazole (1980) J Infect Dis, 141, pp. 317-325
• Freeman, C.D., Klutman, E.N., Lamp, K.C., Metronidazole a therapeuthic review and update (1997) Drugs, 54, pp. 679-708
• Bergan, T., Arnold, E., Pharmacokinetics of metronidazole in healthy volunteers after tablets and suppositories (1980) Chemotherapy, 26, pp. 231-241
• Nitsche, V., Mascher, M., Pharmacokinetics of metronidazole after application on different routes (1981) Procedures of the First European Congress on Bipharmacy and Pharmacokinetics, Technique et Documentation, pp. 169-181. , Clermont Ferrand, part Y
• Mattila, J., Mnnistö, P.T., Mántyla, R., Nykänen, S., Lamminsivi, U., Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route (1983) Antimicrob Agents and Chemother, 23 (5), pp. 721-725
• Lamp, K.C., Freeman, C.D., Klutman, E.N., Lacy, M.K., Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials (1999) J Clin Pharmacokinet, 36, pp. 353-373
• Russell, L.B., Russell, W.L., Frequency and nature of specific-locus mutation induced in female mice by radiation and chemicals: A review (1992) Mutation Res, 296, pp. 107-127
• Kirk, M., Lyon, M.F., Induction of congenital anomalies in offspring of female mice exposed to varying doses of X-rays (1982) Mutation Res, 106, pp. 73-83
• Martínez-Flores, I., Saez, C., Egozcue, J., Garcia, M., Effects of ionizing radiation on oocytes prepubertally irradiated rats (2000) Int J Radiat Biol
• Martínez-Flores, I., Saez, C., Egozcue, J., Garcia, M., Effects of female fertility and germinal cells in prepubertal and adult rats (Rattus norvegicus) after X-ray irradiation (1998) Reprod Toxicol, pp. 215-219
• Bender, M.A., Griggs, H.G., Bedford, J.S., Mechanisms of chromosome aberration production. III. Chemicals and ionizing radiation (1974) Mutation Res, 23, pp. 197-212
• Edwards, D.I., Rowley, D.A., Knox, R.J., Skolimowski, I.M., Knight, R.C., Nature of DNA-damage induced by electrolytically reduced nitroimidazole drugs (1980), 1, p. 561. , Nelsson JD, Grassi C, editors. Current chemotherapy and infectious disease. Washington DC: The American Society for Microbiology; Reichert, W., Buselmaier, W., Vogel, F., Elimination of X-ray induced chromosomal aberrations in the progeny of female mica (1984) Mutation Res, 139, pp. 87-94
• Lau, A.H., Lam, N.P., Piscitelli, S.C., Wilkes, L., Danziger, L.H., Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infective (1992) Clin Pharmacokinet, 23, pp. 328-364

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------